Subscribe to
our newsletters

Subscribe to our newsletters!

Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.

Search in Nordic Life Science Insight

-
January 27, 2020
Medicon Valley Alliance

Lund-based, Follicum, and COBIS-based, Orphazymes, highlighted on the Labiotech-list “20 European Biotech Companies to Follow in 2020”

Lund-based, Follicum, and COBIS-based, Orphazymes, highlighted on the Labiotech-list “20 European Biotech Companies to Follow in 2020”

Leading European Biotech online media, Labiotech.eu, includes two Medicon Valley based companies in their recently published top-20 list “20 European Biotech Companies to Follow in 2020

MVA-member, Lund-based Follicum, which was founded in 2011, develops peptide drugs intended to treat hair loss and diabetes. In 2020, the company plans to start a phase I trial with a drug that has shown potential to stimulate the secretion of insulin and delay the onset of type 1 diabetes. Follicum is also preparing for the start of a phase II trial testing its hair growth treatment.

Danish, Orphazyme, develops therapies for rare diseases that impair the correct folding of proteins, and therefore their function. In 2020, the company will be filing for its first marketing authorization, concerning a treatment for Niemann-Pick disease, in both Europe and the US. Orphazyme also expects to be reporting results from a phase II trial in Gaucher disease.

Last updated:
January 27, 2020

Medicon Valley Alliance

Medicon Valley Alliance (MVA) is a non-profit membership organization in the Danish-Swedish life science cluster Medicon Valley, which is a part of Greater Copenhagen. Our 245 members, who together employ approximately 140.000 people, represents the region’s triple helix and include universities, hospitals, human life science business, regional governments and service providers.

Click here to read more about us!
Get in touch with us!
Visit us
Send us mail

Leading European Biotech online media, Labiotech.eu, includes two Medicon Valley based companies in their recently published top-20 list “20 European Biotech Companies to Follow in 2020

MVA-member, Lund-based Follicum, which was founded in 2011, develops peptide drugs intended to treat hair loss and diabetes. In 2020, the company plans to start a phase I trial with a drug that has shown potential to stimulate the secretion of insulin and delay the onset of type 1 diabetes. Follicum is also preparing for the start of a phase II trial testing its hair growth treatment.

Danish, Orphazyme, develops therapies for rare diseases that impair the correct folding of proteins, and therefore their function. In 2020, the company will be filing for its first marketing authorization, concerning a treatment for Niemann-Pick disease, in both Europe and the US. Orphazyme also expects to be reporting results from a phase II trial in Gaucher disease.

Last updated:
January 27, 2020

Medicon Valley Alliance

Medicon Valley Alliance (MVA) is a non-profit membership organization in the Danish-Swedish life science cluster Medicon Valley, which is a part of Greater Copenhagen. Our 245 members, who together employ approximately 140.000 people, represents the region’s triple helix and include universities, hospitals, human life science business, regional governments and service providers.

Click here to read more about us!
Get in touch with us!
Visit us
Send us mail